Glycopyrronium inhalation, bronchodilator reversibility assessment, and defining asthma: A new paradigm
Author:
Affiliation:
1. Institute of Pulmocare and Research, DG-8, New Town, Action Area-I, Kolkata, West Bengal, India. E-mail: ipcr_india@yahoo.com
Publisher
Medknow
Reference5 articles.
1. Expert panel report 3 (EPR-3): Guidelines for the diagnosis and management of asthma-summary report 2007;Education;J Allergy Clin Immunol,2007
2. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: The GOLD science committee report 2019;Singh;Eur Respir J,2019
3. P253 NVA237 once daily offers rapid and clinically meaningful bronchodilation in COPD patients that is maintained for 24 h: The GLOW1 trial;D'Urzo;Thorax,2011
4. Feasibility of testing bronchodilator responsiveness with glycopyrronium in obstructive airway diseases: The initial appraisal of the pilot experience;Bhattacharyya;J Assoc Chest Physicians,2021
5. COPD and glycopyrronium responsiveness assessment: An appraisal;Bhattacharyya;Lung India,2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3